The current diagnostic guidelines for SMA recommend that Multiplex ligation-dependent probe amplification (MLPA) testing for the SMN gene should be performed first in patients with high clinical suspicion of SMA [21, 22]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.